Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120
about
Pathogenesis of human immunodeficiency virus infectionOptimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene.An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virusInduction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like proteinAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesStructure determination of an anti-HIV-1 Fab 447-52D–peptide complex from an epitaxially twinned data setCrystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigenThe antigenic structure of the HIV gp120 envelope glycoproteinInhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanismsPeptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infectionV3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodiesCharacterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoproteinSurvivors Remorse: antibody-mediated protection against HIV-1.Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop Antibodies.Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in FranceMutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.The capsid gene of feline calicivirus contains linear B-cell epitopes in both variable and conserved regions3D structure model of the principal neutralizing epitope of Minnesota HIV-1 isolate.Dual spatial folds and different local structures of the HIV-1 immunogenic crown in various virus isolates.Conformational preferences of the HIV-1 principal neutralizing determinant.Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.Conformational model for the consensus V3 loop of the envelope protein gp120 of HIV-1 in a 20% trifluoroethanol/water solution.Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia.Protein intrinsic disorder toolbox for comparative analysis of viral proteins.Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genomeVertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain.An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sitesNuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodiesFactors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins.Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers.Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope
P2860
Q24634681-263E84EE-A11D-4359-AAAD-19C3262E86DDQ27469577-6A396306-7EA4-4731-972F-AAC6C33DD8CFQ27485984-A976AED6-23C7-4129-BE6D-C575C04F8E7FQ27486056-E0F69FBA-7252-4DFD-AC38-5DEAD231E2BBQ27486239-A1268144-8D09-4609-9002-49D676877D3AQ27489000-69746D0F-7564-451C-A5F5-31226B88F622Q27650903-F0ACAC54-0133-488F-B57A-C32CD3FD2BF2Q27731780-097C9F79-20EF-4A85-B9E3-A033F7C9C008Q28274698-8DA8362C-682B-4FCE-887F-CDBDA1701040Q28368050-0B9167F0-E4BB-4B0E-9168-32EBF5AF66CFQ28368122-ACC19C87-19CD-4437-8A6C-B9E5A3A8E741Q28369033-BA7FB028-9C40-4127-AD62-FACF6B5C8A49Q28469283-A5169FA9-953A-4A5F-8497-09A1DC4669EEQ28646835-51259ADC-1959-4513-963B-B66A5F1CB442Q28646850-FD15B54F-2038-4BBB-8DA1-EB097E3C5DC0Q30238730-1CC2048B-3325-4300-B0C1-2399BE167EC2Q30416200-E7C05BB1-3D72-44BF-80DB-9A8473A89151Q30417537-3584A9BB-E4E0-45C9-8FFC-9F67486794D0Q30420728-B8828D81-DA0B-4813-9784-51F8DD427BE4Q30769950-859EF3C1-D704-41E7-AD14-BDEBC466E5B1Q30886684-ECEE6A2C-B812-4AEE-842B-8DD76E7F5AD6Q30952700-4BB2FA03-7790-47CC-AB7D-66FB7939700DQ31010762-4147AA44-3666-47A7-B29C-A8C34F09B2B6Q31112947-C2E4AA04-F6F4-4101-B43B-E4B133876178Q31911259-1B88BBC2-0703-40E8-886A-0ECC92624465Q32157115-5823D319-25D4-4F81-94DE-29693FC35030Q33328140-85812DD4-86E9-4CB0-B432-BC11627ECC6CQ33373579-D7388D7B-5776-4C6F-B9B0-CFE5F9ED00C6Q33407962-7FBED207-A4D6-4848-9991-2654CC2E09B5Q33564746-A64D44D7-FEB9-4391-9609-2993F85476FDQ33570776-480856D2-1353-4D29-A3A5-74EAF2033A12Q33587317-E981C8AF-BE72-41BA-8E5C-0F3FC504A4E9Q33614461-4881AE5D-5ECB-4A59-904C-A37546519931Q33639792-E4B5C23E-096D-49B6-A133-16D7A79A431CQ33649657-C3CCBA30-8034-4AC1-A6AD-A537411A1592Q33671780-92641CFD-F1BC-4E5C-A49D-21375B494261Q33783353-8885A839-0016-4235-A9AC-AA59F38EA779Q33786049-7379D7FB-6604-4194-A437-C047288D8A03Q33836042-1D97E01F-7041-4D26-A242-365883AACBA6Q33839402-3FBF8AF7-4097-49E5-8402-1BAF74CC1995
P2860
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Antibodies that inhibit fusion ...... e of the viral envelope, gp120
@ast
Antibodies that inhibit fusion ...... e of the viral envelope, gp120
@en
Antibodies that inhibit fusion ...... of the viral envelope, gp120.
@nl
type
label
Antibodies that inhibit fusion ...... e of the viral envelope, gp120
@ast
Antibodies that inhibit fusion ...... e of the viral envelope, gp120
@en
Antibodies that inhibit fusion ...... of the viral envelope, gp120.
@nl
prefLabel
Antibodies that inhibit fusion ...... e of the viral envelope, gp120
@ast
Antibodies that inhibit fusion ...... e of the viral envelope, gp120
@en
Antibodies that inhibit fusion ...... of the viral envelope, gp120.
@nl
P2093
P2860
P356
P1476
Antibodies that inhibit fusion ...... e of the viral envelope, gp120
@en
P2093
A Langlois
J R Rusche
K Javaherian
L O Arthur
P J Fischinger
R Grimaila
P2860
P304
P356
10.1073/PNAS.85.9.3198
P407
P50
P577
1988-05-01T00:00:00Z